Status: current, Sufficiently defined by necessary conditions definition status. Date: 28-Feb 2022. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4945161013 | Product containing ambroxol and guaifenesin and terbutaline in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 4945162018 | Ambroxol- and guaifenesin- and terbutaline-containing product in oral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing ambroxol and guaifenesin and terbutaline in oral dose form (medicinal product form) | Is a | Product containing ambroxol in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing ambroxol and guaifenesin and terbutaline in oral dose form (medicinal product form) | Is a | Product containing ambroxol and guaifenesin and terbutaline (medicinal product) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing ambroxol and guaifenesin and terbutaline in oral dose form (medicinal product form) | Is a | Product containing terbutaline in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing ambroxol and guaifenesin and terbutaline in oral dose form (medicinal product form) | Is a | Product containing guaifenesin in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing ambroxol and guaifenesin and terbutaline in oral dose form (medicinal product form) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing ambroxol and guaifenesin and terbutaline in oral dose form (medicinal product form) | Plays role | Expectorant therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing ambroxol and guaifenesin and terbutaline in oral dose form (medicinal product form) | Plays role | Mucolytic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing ambroxol and guaifenesin and terbutaline in oral dose form (medicinal product form) | Has active ingredient | Terbutaline | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing ambroxol and guaifenesin and terbutaline in oral dose form (medicinal product form) | Has active ingredient | Ambroxol | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing ambroxol and guaifenesin and terbutaline in oral dose form (medicinal product form) | Has active ingredient | Guaifenesin | true | Inferred relationship | Existential restriction modifier | 3 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only ambroxol and guaifenesin and terbutaline in oral dose form (medicinal product form) | Is a | True | Product containing ambroxol and guaifenesin and terbutaline in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR